Skip to main content
OpenTrials
Completed

NCT Number: NCT00232219

Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion

The purpose of this study is to investigate whether fish oil supplements may be beneficial in preventing the recurrence of atrial fibrillation after cardioversion.

Atrial fibrillation is a heart condition which can sometimes be successfully treated by a cardioversion.

Cardioversion involves resetting the heart back to normal with the use of electric current.

There is a tendency for the atrial fibrillation to recur , days weeks or even months after the cardioversion.

Fish oil supplements may be of benefit to patients with heart problems Recent evidence suggests that fish oils may be beneficial to patients with rhythm disturbances.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Royal Melbourne hospital

Melbourne, Victoria, 3050, Australia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with persistent Atrial Fibrillation on Warfarin.

Exclusion criteria

  • paroxysmal atrial fibrillation with self terminating episodes.
  • left atrial size>6.0cm
  • myocardial infarction in the previous 6 months.
  • contraindications to amiodarone use .
  • cardiac surgery in the previous 3 months .
  • an acute reversible illness contributing to the development of af
  • a QTc interval > 480ms.
  • pregnancy

Treatment and study plan

Fish oil

Drug

Primary outcomes

  1. Recurrence of atrial fibrillation followed cardioversion

    Time frame: 1 year

Other outcomes

  1. Safety and tolerability

    Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Melbourne Health

Other

Registry information

Official study title

Use of Fish Oils to Reduce Recurrence of Atrial Fibrillation Following DC Cardioversion.

Important dates

Study start
2003
Primary completion
2013
Study completion
2013
First posted
Oct 4, 2005
Registry last updated
May 5, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.